510(k) K101683

INFINITI CYP2C19 ASSAY by Autogenomics, Incorporated — Product Code NTI

K101683 is an FDA 510(k) premarket notification submitted by Autogenomics, Incorporated for the device "INFINITI CYP2C19 ASSAY". The FDA issued a decision of Substantially Equivalent on Oct 25, 2010. The device falls under product code NTI (Drug Metabolizing Enzyme Genotyping Systems), a Class II device regulated under 21 CFR 862.3360. Autogenomics, Incorporated has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 25, 2010
Date Received
Jun 15, 2010
Clearance Type
Abbreviated
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Drug Metabolizing Enzyme Genotyping Systems
Device Class
Class II
Regulation Number
862.3360
Review Panel
TX
Submission Type
510(k)

Intended to identify the presence or absence of human genotypic markers encoding drug metaboizing enzymes using dna originating from clinical samples. This type of assay can be used as an aid determining treatment choice and individualizing treatment dose for therapeutics that are metabolized primarily by the specific enzyme tested by the system.

Need the full FDA record for Autogenomics, Incorporated? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K101683. Report a data issue: hello@regdatalab.com.